Director/PDMR Shareholding

Convatec Group PLC
18 March 2025
 

18 March 2025

Convatec Group Plc
("Convatec" or "the Company")

Director/ PDMR Shareholding 

The Company has been notified of the following transactions in relation to Persons Discharging Managerial Responsibility ("PDMR") in respect of ordinary shares of 10 pence each in the Company ("Shares").

Vesting of Awards under the Company's Long Term Incentive Plan ("LTIP")

On 14 March 2025, conditional share awards granted to Jonny Mason, Chief Financial Officer in 2022 under the LTIP in the form of Performance Share Awards ("PSA") vested and on 18 March 2025, shares were sold to satisfy income tax and National Insurance ("NI") liabilities:

Shares vested

Shares sold to satisfy income tax & NI liabilities

Share price

Total shares acquired

516,368

 

239,778

£2.599537

276,590

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Jonny Mason

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer and PDMR

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Convatec Group Plc

b)

 

LEI

 

213800LS272L4FIDOH92

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Convatec Group Plc



Identification code

GB00BD3VFW73



b)

 

Nature of the transaction

 

 

Vesting of PSA under the LTIP.

 

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£0

516,368

d)

 

Aggregated information




- Aggregated volume

N/A - single transaction



- Price




e)

 

Date of the transaction

 

14 March 2025

f)

 

Place of the transaction

 

Outside a trading venue

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in Convatec Group Plc



Identification code

GB00BD3VFW73



b)

 

Nature of the transaction

 

 

Immediate sale of shares awarded under the LTIP to cover tax and national insurance liabilities.

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£2.599537

239,778

d)

 

Aggregated information




- Aggregated volume

N/A - single transaction



- Price




e)

 

Date of the transaction

 

18 March 2025

f)

 

Place of the transaction

 

London Stock Exchange

 

Enquiries

 

James Kerton Company Secretary                                                          
Tel: +44 (7827) 036059
Email: cosec@convatec.com 

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation

About Convatec

 

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide our products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Convatec's revenues in 2024 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100